Cargando…
Autoimmunity plays a role in the onset of diabetes after 40 years of age
AIMS/HYPOTHESIS: Type 1 and type 2 diabetes differ with respect to pathophysiological factors such as beta cell function, insulin resistance and phenotypic appearance, but there may be overlap between the two forms of diabetes. However, there are relatively few prospective studies that have characte...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946728/ https://www.ncbi.nlm.nih.gov/pubmed/31713011 http://dx.doi.org/10.1007/s00125-019-05016-3 |
_version_ | 1783485423297757184 |
---|---|
author | Rolandsson, Olov Hampe, Christiane S. Sharp, Stephen J. Ardanaz, Eva Boeing, Heiner Fagherazzi, Guy Mancini, Francesca Romana Nilsson, Peter M. Overvad, Kim Chirlaque, Maria-Dolores Dorronsoro, Miren Gunter, Marc J. Kaaks, Rudolf Key, Timothy J. Khaw, Kay-Tee Krogh, Vittorio Kühn, Tilman Palli, Domenico Panico, Salvatore Sacerdote, Carlotta Sánchez, Maria-José Severi, Gianluca Spijkerman, Annemieke M. W. Tumino, Rosario van der Schouw, Yvonne T. Riboli, Elio Forouhi, Nita G. Langenberg, Claudia Wareham, Nicholas J. |
author_facet | Rolandsson, Olov Hampe, Christiane S. Sharp, Stephen J. Ardanaz, Eva Boeing, Heiner Fagherazzi, Guy Mancini, Francesca Romana Nilsson, Peter M. Overvad, Kim Chirlaque, Maria-Dolores Dorronsoro, Miren Gunter, Marc J. Kaaks, Rudolf Key, Timothy J. Khaw, Kay-Tee Krogh, Vittorio Kühn, Tilman Palli, Domenico Panico, Salvatore Sacerdote, Carlotta Sánchez, Maria-José Severi, Gianluca Spijkerman, Annemieke M. W. Tumino, Rosario van der Schouw, Yvonne T. Riboli, Elio Forouhi, Nita G. Langenberg, Claudia Wareham, Nicholas J. |
author_sort | Rolandsson, Olov |
collection | PubMed |
description | AIMS/HYPOTHESIS: Type 1 and type 2 diabetes differ with respect to pathophysiological factors such as beta cell function, insulin resistance and phenotypic appearance, but there may be overlap between the two forms of diabetes. However, there are relatively few prospective studies that have characterised the relationship between autoimmunity and incident diabetes. We investigated associations of antibodies against the 65 kDa isoform of GAD (GAD65) with type 1 diabetes and type 2 diabetes genetic risk scores and incident diabetes in adults in European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct, a case-cohort study nested in the EPIC cohort. METHODS: GAD65 antibodies were analysed in EPIC participants (over 40 years of age and free of known diabetes at baseline) by radioligand binding assay in a random subcohort (n = 15,802) and in incident diabetes cases (n = 11,981). Type 1 diabetes and type 2 diabetes genetic risk scores were calculated. Associations between GAD65 antibodies and incident diabetes were estimated using Prentice-weighted Cox regression. RESULTS: GAD65 antibody positivity at baseline was associated with development of diabetes during a median follow-up time of 10.9 years (HR for GAD65 antibody positive vs negative 1.78; 95% CI 1.43, 2.20) after adjustment for sex, centre, physical activity, smoking status and education. The genetic risk score for type 1 diabetes but not type 2 diabetes was associated with GAD65 antibody positivity in both the subcohort (OR per SD genetic risk 1.24; 95% CI 1.03, 1.50) and incident cases (OR 1.97; 95% CI 1.72, 2.26) after adjusting for age and sex. The risk of incident diabetes in those in the top tertile of the type 1 diabetes genetic risk score who were also GAD65 antibody positive was 3.23 (95% CI 2.10, 4.97) compared with all other individuals, suggesting that 1.8% of incident diabetes in adults was attributable to this combination of risk factors. CONCLUSIONS/INTERPRETATION: Our study indicates that incident diabetes in adults has an element of autoimmune aetiology. Thus, there might be a reason to re-evaluate the present subclassification of diabetes in adulthood. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-019-05016-3) contains peer-reviwed but unedited supplementary material, which is available to authorised users. |
format | Online Article Text |
id | pubmed-6946728 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-69467282020-01-21 Autoimmunity plays a role in the onset of diabetes after 40 years of age Rolandsson, Olov Hampe, Christiane S. Sharp, Stephen J. Ardanaz, Eva Boeing, Heiner Fagherazzi, Guy Mancini, Francesca Romana Nilsson, Peter M. Overvad, Kim Chirlaque, Maria-Dolores Dorronsoro, Miren Gunter, Marc J. Kaaks, Rudolf Key, Timothy J. Khaw, Kay-Tee Krogh, Vittorio Kühn, Tilman Palli, Domenico Panico, Salvatore Sacerdote, Carlotta Sánchez, Maria-José Severi, Gianluca Spijkerman, Annemieke M. W. Tumino, Rosario van der Schouw, Yvonne T. Riboli, Elio Forouhi, Nita G. Langenberg, Claudia Wareham, Nicholas J. Diabetologia Article AIMS/HYPOTHESIS: Type 1 and type 2 diabetes differ with respect to pathophysiological factors such as beta cell function, insulin resistance and phenotypic appearance, but there may be overlap between the two forms of diabetes. However, there are relatively few prospective studies that have characterised the relationship between autoimmunity and incident diabetes. We investigated associations of antibodies against the 65 kDa isoform of GAD (GAD65) with type 1 diabetes and type 2 diabetes genetic risk scores and incident diabetes in adults in European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct, a case-cohort study nested in the EPIC cohort. METHODS: GAD65 antibodies were analysed in EPIC participants (over 40 years of age and free of known diabetes at baseline) by radioligand binding assay in a random subcohort (n = 15,802) and in incident diabetes cases (n = 11,981). Type 1 diabetes and type 2 diabetes genetic risk scores were calculated. Associations between GAD65 antibodies and incident diabetes were estimated using Prentice-weighted Cox regression. RESULTS: GAD65 antibody positivity at baseline was associated with development of diabetes during a median follow-up time of 10.9 years (HR for GAD65 antibody positive vs negative 1.78; 95% CI 1.43, 2.20) after adjustment for sex, centre, physical activity, smoking status and education. The genetic risk score for type 1 diabetes but not type 2 diabetes was associated with GAD65 antibody positivity in both the subcohort (OR per SD genetic risk 1.24; 95% CI 1.03, 1.50) and incident cases (OR 1.97; 95% CI 1.72, 2.26) after adjusting for age and sex. The risk of incident diabetes in those in the top tertile of the type 1 diabetes genetic risk score who were also GAD65 antibody positive was 3.23 (95% CI 2.10, 4.97) compared with all other individuals, suggesting that 1.8% of incident diabetes in adults was attributable to this combination of risk factors. CONCLUSIONS/INTERPRETATION: Our study indicates that incident diabetes in adults has an element of autoimmune aetiology. Thus, there might be a reason to re-evaluate the present subclassification of diabetes in adulthood. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-019-05016-3) contains peer-reviwed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2019-11-11 2020 /pmc/articles/PMC6946728/ /pubmed/31713011 http://dx.doi.org/10.1007/s00125-019-05016-3 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Article Rolandsson, Olov Hampe, Christiane S. Sharp, Stephen J. Ardanaz, Eva Boeing, Heiner Fagherazzi, Guy Mancini, Francesca Romana Nilsson, Peter M. Overvad, Kim Chirlaque, Maria-Dolores Dorronsoro, Miren Gunter, Marc J. Kaaks, Rudolf Key, Timothy J. Khaw, Kay-Tee Krogh, Vittorio Kühn, Tilman Palli, Domenico Panico, Salvatore Sacerdote, Carlotta Sánchez, Maria-José Severi, Gianluca Spijkerman, Annemieke M. W. Tumino, Rosario van der Schouw, Yvonne T. Riboli, Elio Forouhi, Nita G. Langenberg, Claudia Wareham, Nicholas J. Autoimmunity plays a role in the onset of diabetes after 40 years of age |
title | Autoimmunity plays a role in the onset of diabetes after 40 years of age |
title_full | Autoimmunity plays a role in the onset of diabetes after 40 years of age |
title_fullStr | Autoimmunity plays a role in the onset of diabetes after 40 years of age |
title_full_unstemmed | Autoimmunity plays a role in the onset of diabetes after 40 years of age |
title_short | Autoimmunity plays a role in the onset of diabetes after 40 years of age |
title_sort | autoimmunity plays a role in the onset of diabetes after 40 years of age |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946728/ https://www.ncbi.nlm.nih.gov/pubmed/31713011 http://dx.doi.org/10.1007/s00125-019-05016-3 |
work_keys_str_mv | AT rolandssonolov autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT hampechristianes autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT sharpstephenj autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT ardanazeva autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT boeingheiner autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT fagherazziguy autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT mancinifrancescaromana autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT nilssonpeterm autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT overvadkim autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT chirlaquemariadolores autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT dorronsoromiren autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT guntermarcj autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT kaaksrudolf autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT keytimothyj autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT khawkaytee autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT kroghvittorio autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT kuhntilman autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT pallidomenico autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT panicosalvatore autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT sacerdotecarlotta autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT sanchezmariajose autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT severigianluca autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT spijkermanannemiekemw autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT tuminorosario autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT vanderschouwyvonnet autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT ribolielio autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT forouhinitag autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT langenbergclaudia autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage AT warehamnicholasj autoimmunityplaysaroleintheonsetofdiabetesafter40yearsofage |